{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:45Z","timestamp":1791286665386,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.atherosclerosis.2008.11.024","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T11:16:48Z","timestamp":1228475808000},"page":"113-119","source":"Crossref","is-referenced-by-count":67,"title":["Pre-B cell colony enhancing factor (PBEF)\/visfatin induces secretion of MCP-1 in human endothelial cells: Role in visfatin-induced angiogenesis"],"prefix":"10.1016","volume":"205","author":[{"given":"Raghu","family":"Adya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bee K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal S.","family":"Randeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","article-title":"Metabolic syndrome: a clinical and molecular perspective","volume":"56","author":"Moller","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib5","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.22833","article-title":"Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities","volume":"56","author":"Brentano","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib6","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","article-title":"Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin","volume":"91","author":"Tan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/dc07-1544","article-title":"Nuclear factor-kappa-B induction by visfatin in human vascular endothelial cells: its role in MMP-2\/9 production and activation","volume":"31","author":"Adya","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/Akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"78","author":"Adya","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00024382-199509000-00001","article-title":"The role of CXC chemokines as regulators of angiogenesis","volume":"4","author":"Strieter","year":"1995","journal-title":"Shock"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"Salcedo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","article-title":"Shaping the nuclear action of NF-kappaB","volume":"5","author":"Chen","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00223-006-0155-7","article-title":"Insulin-like effects of visfatin on human osteoblasts","volume":"80","author":"Xie","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib15","first-page":"450","article-title":"Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells","volume":"86","author":"Aljada","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"3","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0046-8177(93)90166-E","article-title":"Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody","volume":"241","author":"Takeya","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.ijo.0803032","article-title":"Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue","volume":"29","author":"Fain","year":"2005","journal-title":"Int J Obes"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib20","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1074\/jbc.M608083200","article-title":"ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages","volume":"282","author":"Cruz","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbamcr.2008.01.004","article-title":"Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells","volume":"1783","author":"Kim","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"Salcedo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","article-title":"Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A","volume":"105","author":"Hong","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1189\/jlb.0305127","article-title":"MCP-1\/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes","volume":"79","author":"Sakai","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0903421","article-title":"MCP-1-dependent signaling in CCR2(\u2212\/\u2212) aortic smooth muscle cells","volume":"75","author":"Schecter","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.11.024_bib26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Hajime","year":"2006","journal-title":"J Clin Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008008204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008008204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T21:14:13Z","timestamp":1589318053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008008204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0021915008008204"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.11.024","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}